pr-inside.com
Print
Inovio Biomedical Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Inovio Biomedical Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released



companiesandmarkets.com
2009-11-10 02:17:02 - Inovio Biomedical Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/inovio-biome ..

Inovio Biomedical Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Inovio Biomedical Corporation (Inovio) is a biomedical company, engaged in the development of DNA-based vaccines and immunotherapies using its proprietary Electroporation Therapy (EPT) technology, for the treatment of treat cancer and chronic infectious diseases. Currently, it is developing two main franchises based on its MedPulser Electroporation System namely, Oncology

 

 

and DNA vaccines. The company is headquartered in California, the US. On June 1, 2009, Inovio Biomedical Corporation completed the merger agreement with VGX Pharmaceuticals, Inc.(formerly known as Viral Genomix, Inc.) to form a leading vaccine discovery, development and delivery company

The Inovio Biomedical Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.

Author:
Mike King
e-mail
Web: http://www.companiesandmarkets.com
Telefon: London: +44 (0) 203 086 8600




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.